Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment
Asia-Pacific Journal of Oncology Nursing · 2026-12 · 13 · 101012
DOI: 10.1016/j.apjon.2026.101012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2026-12. Verfasst von Pei-Hung Chang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Keelung, Keelung City, Taiwan. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Objective
To develop a brief, clinician-administered Chinese-language Breakthrough Cancer Pain Assessment (BCPA) instrument and evaluate its content validity, inter-rater reliability, and ability to detect change in selected rescue medication-related items.
Methods
The 11-item BCPA was developed from literature review, clinical input, and three Delphi rounds with 14 experts. Inter-rater reliability was evaluated through independent physician and nurse interviews with 30 participants with cancer and breakthrough cancer pain (BTcP). In an exploratory observational phase, selected BCPA responses were compared in 77 participants before and 7 days after routine-care initiation of fentanyl buccal soluble film.
Results
In the third Delphi round, all items had an item-level content validity index of 1.00 and the scale-level content validity index based on universal agreement (S-CVI/UA) was 1.00. Kappa coefficients for categorical items ranged from 0.507 to 0.888, and intraclass correlation coefficient [ICC(2,1)] values for numerical items ranged from 0.836 to 0.979. The proportion reporting pain relief within 15 minutes increased from 33.8% to 66.2% (matched-pairs odds ratio, 4.57; 95% CI, 2.02-10.35; P < 0.001). Mean satisfaction with the effectiveness of rescue medication increased from 5.96 to 7.60, and perceived improvement in sleep and mood increased from 6.01 to 7.40 (both P < 0.001).
Conclusions
The Chinese-language BCPA showed preliminary content validity and inter-rater reliability. Selected rescue medication-related items detected pre/post changes in an uncontrolled observational sample. Further evaluation of response processes, criterion-related validity, cross-cultural validity, and responsiveness is required before routine clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Keelung, Keelung City, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Otolaryngology-Head Neck Surgery, MacKay Memorial Hospital, Taipei, Taiwan.
- Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
- Division of Oncology and Hematology, Department of Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Zitieren
APA
Chang, P. H., Wang, C. H., Leu, Y. S., Chou, W. C., Teng, C. J., Shao, Y. Y., Wu, C. C., Wang, T. Y., Bai, L. Y., Chen, J. H., Chen, Y. Y., Hsiao, H. H., Lu, H. J., Su, Y. C., Tsai, J. H., & Chen, M. L. (2026). Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment. Asia-Pacific Journal of Oncology Nursing, 13, 101012. https://doi.org/10.1016/j.apjon.2026.101012
Vancouver
Chang PH, Wang CH, Leu YS, Chou WC, Teng CJ, Shao YY, et al. Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment. Asia-Pacific Journal of Oncology Nursing. 2026;13:101012. doi:10.1016/j.apjon.2026.101012
BibTeX
@article{Chang2026,
author = {Chang, Pei-Hung and Wang, Cheng-Hsu and Leu, Yi-Shing and Chou, Wen-Chi and Teng, Chung-Jen and Shao, Yu-Yun and Wu, Chih Cheng and Wang, Ting-Yao and Bai, Li-Yuan and Chen, Jia-Hong and Chen, Yen-Yang and Hsiao, Hui-Hua and Lu, Hsueh-Ju and Su, Yu-Chieh and Tsai, Jui-Hung and Chen, Mei-Ling},
title = {Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2026},
volume = {13},
pages = {101012},
doi = {10.1016/j.apjon.2026.101012}
}
EUVIMED